Abstract
Objective The study aimed at evaluating the effect of pharmaceutical care programme on blood pressure and quality of life of patients who visit a Nigerian community pharmacy. Method A non-randomised, single-site, crossover design was used. Patients served as their own control. They underwent 5 months of usual care and another 5 months of pharmaceutical care. Main outcome measure Blood pressure and quality of life measured before implementation of pharmaceutical care and at the end served as main outcome measures. Other end-points assessed at baseline and at the end of investigation included smoking cessation, adherence to therapy, exercise, salt restriction, alcohol moderation and self blood pressure measurement. Results Twenty four (24) patients out of the 40 recruited completed the study. Mean reductions were significant after pharmaceutical care intervention for systolic BP (14.3 ± 14.4 mmHg) and diastolic BP (10.8 ± 10.7 mmHg). There was a significant mean increase in number of patients that adhered to salt restriction (−36%), aerobic exercise (−46%), self BP measurement (−46%), alcohol moderation (−33%) and drug adherence (−16.7%). There was a positive increase of −11.4 and −3.2 for physical health and social health domain of quality of life evaluation respectively. Conclusion Pharmaceutical care programme could produce a beneficial effect on hypertensive patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533–43.
Pharmacists Council of Nigeria. Four-part compendium of minimum standards of pharmaceutical care in Nigeria. Abuja: 2005.
World Health Organization. Introduction, administration, scoring, and generic version of the assessment. [Online] 2002. [Cited 2006 Jan]. Available from: URL: http://www.who.int/mental_health/media/en/76.pdf.
Chobanian AV, Bakris JL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560.
Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH – sodium trial. Ann Intern Med 2001;135:1019.
Ebrahim S. Detection, adherence and control of hypertension for the prevention of stroke: a systematic review. Health Technol Assess 1998;2:22–3.
Whelton PK, He J, Appel LJ. Primary prevention of hypertension: Clinical and public health advisory from The National high blood pressure education program. JAMA 2002;288:1882–8.
Cutler JA, McMahon SW, Furberg CD. Controlled clinical trials of drug treatment for hypertension: a review. Hypertension. 1989;13:136–4.
Cater BL, Barnette DG, Chriscilles E, Mazzotti GJ, Asali ZJ. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacother 1997;17(6):1274–85.
Dungan BD. Enhancing community pharmacy through advanced pharmacy practice experiences. Am J Pharma Educ 2006;70(1):1–3.
Acknowledgements
We thank B.O. Ebugosi, the managing director of Ebus Pharmacy, Port Harcourt for partly funding and providing the necessary facilities for this study and Asor A.C. for his help and support during the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aguwa, C.N., Ukwe, C.V. & Ekwunife, O.I. Effect of pharmaceutical care programme on blood pressure and quality of life in a nigerian pharmacy. Pharm World Sci 30, 107–110 (2008). https://doi.org/10.1007/s11096-007-9151-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-007-9151-x